Andrew E. Greenstein
Symposium on Proteases and the Tumouri Microenvironment 2017
Days
Monday, 24th July
Tuesday, 25th July
Wednesday, 26th July
Search
Speakers
Andrew E. Greenstein
Senior Research Scientist at Gilead Sciences Biologics and Target Biology Research Group
Abstracts this author is presenting:
Andecaliximab (GS-5745): A monoclonal antibody inhibitor of matrix metalloproteinase 9
—
Session 7 - Drug Discovery & Targeted Therapeutics